A study to see the efficacy of Atosiban given before Embryo Transfer on In vitro Fertilisation

A Randomized Controlled Trial to study the efficacy of administration of Atosiban before Embryo Transfer on In vitro Fertilisation - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080120

Enrollment

100

Registered

2025-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N83- Noninflammatory disorders of ovary, fallopian tube and broad ligament

Interventions

Intervention1: Atosiban: To give Atosiban (Uterine muscle relaxant), 6.75mg/0.9ml intravenous bolus to the patient , 30 minutes prior to Embryo transfer Control Intervention1: No treatment: No treatme

Eligibility

Inclusion criteria

Inclusion criteria: 1 BMI less than 30kg per m2 2 Diagnosed with primary or secondary infertility 3 Normal uterus on 2D ultrasonography 4 Endometrial thickness greater than 7mm on the day of starting progesterone 5 Good quality embryo (Grade A Cleavage stage embryo or blastocyst)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate Clinical pregnancy rate= Number of clinical pregnancies/Number of Embryo transfer cycles*100 Timepoint: 2 months 4 months	—

Secondary

Measure	Time frame
1 Implantation rate 2 Biochemical pregnancy 3 First trimester miscarriageTimepoint: 2 months 4 months	—

Countries

India

Contacts

Public ContactDr Aashna Arora

Akanksha IVF Centre

aashnalhmc@gmail.com9315489342

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026